Patients' preferences for chemotherapy in non-small-cell lung cancer: a systematic review.
about
Patients' preferences: a discrete-choice experiment for treatment of non-small-cell lung cancerPredictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapyEvidence-practice gaps in lung cancer: A scoping review.Intentions for bilateral mastectomy among newly diagnosed breast cancer patientsCancer patients' trade-offs among efficacy, toxicity, and out-of-pocket cost in the curative and noncurative setting.Intraoperative radiotherapy for early breast cancer: do health professionals choose convenience or risk?Decisions for lung cancer chemotherapy: the influence of physician and patient factors.A systematic review of patient preference elicitation methods in the treatment of colorectal cancer.Preferences of lung cancer patients for treatment and decision-making: a systematic literature review.Lung cancer chemotherapy decisions in older patients: the role of patient preference and interactions with physicians.What matters in type 2 diabetes mellitus oral treatment? A discrete choice experiment to evaluate patient preferences.Methods to perform systematic reviews of patient preferences: a literature survey.Patient value: Perspectives from the advocacy community.Estimation of an optimal chemotherapy utilization rate for malignant pleural mesothelioma: an evidence-based benchmark for cancer care.Improvement in population-based survival of stage IV NSCLC due to increased use of chemotherapy.Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology.Current status of chemotherapy use and clinical outcome in octogenarians with advanced non-small cell lung cancer.
P2860
Q28396145-8746FA87-6C31-45FE-A717-7B8AD2555E89Q35869320-C81C195C-96D4-4FBA-9BD3-351154AD7AE6Q36162124-283A0D71-6A97-4EA0-890C-BB78029955C5Q36943042-AF8D6BDC-7186-48E5-8384-6438644EA6A0Q37379577-6DD706DB-8833-4B4D-9A58-8B9BBB9E723CQ37533221-7055B576-4472-4AA0-B5E1-B5B0F963F8D0Q37879997-41AE9C00-E9AD-46F0-B962-82C0F68999B3Q38243162-3663257A-7D9A-4495-B93C-0AD79E01B515Q38671666-A74359E2-AC3F-49A6-93AD-12B3E9059791Q39251171-3245A20E-05F7-48E6-9154-AD4A7E1FBCF4Q40196385-76EB6E3C-F3CF-47D5-A8B3-74149B04BC94Q47133950-0EE0AAC3-3343-401F-83FF-D9DEC321AEF1Q47682226-E891848A-4CC1-4FD5-BF7F-7C6652363928Q48060347-2784EE58-46A3-4871-88F9-FE8F1C44F388Q48544302-BE57ADBD-8A3F-477D-9429-F908CEAE9836Q53061916-B3E953CE-63DC-491B-BB17-C17C98CA36C7Q54308862-6DBD2839-057E-4413-A419-6212FF3EFCCF
P2860
Patients' preferences for chemotherapy in non-small-cell lung cancer: a systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Patients' preferences for chem ...... g cancer: a systematic review.
@en
Patients' preferences for chem ...... g cancer: a systematic review.
@nl
type
label
Patients' preferences for chem ...... g cancer: a systematic review.
@en
Patients' preferences for chem ...... g cancer: a systematic review.
@nl
prefLabel
Patients' preferences for chem ...... g cancer: a systematic review.
@en
Patients' preferences for chem ...... g cancer: a systematic review.
@nl
P2093
P1433
P1476
Patients' preferences for chem ...... g cancer: a systematic review.
@en
P2093
Mahmood Alam
Martin R Stockler
Prunella Blinman
Sue-Anne McLachlan
Vlatka Duric
P304
P356
10.1016/J.LUNGCAN.2010.05.001
P577
2010-05-31T00:00:00Z